I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| retinal ganglion cell | 4 studies | 66% ± 23% | |
| GABAergic neuron | 4 studies | 39% ± 16% | |
| glutamatergic neuron | 3 studies | 57% ± 13% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| retinal ganglion cell | 4 studies | 66% ± 23% | |
| GABAergic neuron | 4 studies | 39% ± 16% | |
| glutamatergic neuron | 3 studies | 57% ± 13% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 37% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 2068.67 | 2632 / 2642 | 95% | 4.77 | 671 / 705 |
| intestine | 88% | 611.56 | 851 / 966 | 86% | 3.38 | 454 / 527 |
| kidney | 84% | 247.03 | 75 / 89 | 88% | 9.15 | 796 / 901 |
| lung | 89% | 585.32 | 516 / 578 | 73% | 4.09 | 845 / 1155 |
| prostate | 62% | 166.82 | 151 / 245 | 98% | 4.05 | 490 / 502 |
| stomach | 79% | 299.53 | 284 / 359 | 80% | 3.21 | 229 / 286 |
| pancreas | 70% | 179.83 | 230 / 328 | 58% | 1.36 | 104 / 178 |
| esophagus | 60% | 314.11 | 862 / 1445 | 49% | 1.99 | 90 / 183 |
| heart | 89% | 621.49 | 763 / 861 | 0% | 0 | 0 / 0 |
| thymus | 58% | 132.48 | 377 / 653 | 18% | 0.41 | 111 / 605 |
| bladder | 24% | 60.00 | 5 / 21 | 51% | 2.13 | 257 / 504 |
| adrenal gland | 6% | 13.59 | 15 / 258 | 65% | 2.17 | 150 / 230 |
| breast | 10% | 21.82 | 47 / 459 | 57% | 2.17 | 633 / 1118 |
| ovary | 2% | 4.10 | 3 / 180 | 55% | 1.78 | 237 / 430 |
| uterus | 11% | 22.25 | 18 / 170 | 39% | 1.92 | 180 / 459 |
| muscle | 47% | 116.92 | 380 / 803 | 0% | 0 | 0 / 0 |
| skin | 5% | 10.11 | 91 / 1809 | 34% | 0.97 | 159 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 20% | 0.56 | 9 / 45 |
| peripheral blood | 19% | 247.82 | 173 / 929 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 11% | 0.33 | 45 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 10% | 0.16 | 3 / 29 |
| eye | 0% | 0 | 0 / 0 | 6% | 0.28 | 5 / 80 |
| adipose | 5% | 10.75 | 61 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 5% | 10.23 | 12 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 1% | 2.73 | 12 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0036211 | Biological process | protein modification process |
| GO_0009064 | Biological process | glutamine family amino acid metabolic process |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0072590 | Molecular function | N-acetyl-L-aspartate-L-glutamate ligase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | RIMKLA |
| Protein name | N-acetylaspartylglutamate synthase A (NAAG synthetase A) (NAAGS) (EC 6.3.2.41) (N-acetylaspartylglutamylglutamate synthase A) (EC 6.3.2.42) (Ribosomal protein S6 modification-like protein A) Ribosomal modification protein rimK like family member A |
| Synonyms | FAM80A |
| Description | FUNCTION: Catalyzes the synthesis of N-acetyl-L-aspartyl-L-glutamate (NAAG) and N-acetyl-L-aspartyl-L-glutamyl-L-glutamate. . |
| Accessions | X1WI25 Q8IXN7 ENST00000410070.6 ENST00000431473.4 |
